Skip to main content
Springer logoLink to Springer
. 2024 May 18;41(7):3013. doi: 10.1007/s12325-024-02894-x

Correction to: Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies

Nandita Khera 1, Marie Louise Edwards 2, Yan Song 3, Rochelle Sun 3, Rocio Manghani 4, Heayoung Shin 4, Ronit Simantov 4, James Signorovitch 3, Smitha Sivaraman 4, Usama Gergis 5,
PMCID: PMC11213780  PMID: 38762585

Correction to: Adv Ther (2024) 41:1637–1651 10.1007/s12325-023-02771-z

In the original article, the text in the discussion section was published incorrectly as “In the sensitivity analysis, it was assumed that HI patients followed the same racial distribution as unrelated bone marrow or peripheral blood donors”. The correct sentence is “In the sensitivity analysis, it was assumed that HI patients followed the same racial distribution as related bone marrow or peripheral blood donors”.

The original article has been corrected.


Articles from Advances in Therapy are provided here courtesy of Springer

RESOURCES